Abstract
Background
Saudi Arabia recently launched a national colorectal cancer (CRC) screening program. Successful control of CRC depends not only on public acceptance but also on sustained adherence and adequate knowledge of CRC symptoms and risk factors. This study evaluated the acceptance, adherence, and knowledge of CRC in the Qassim region, and explored the barriers and facilitators of fecal immunochemical test (FIT) uptake.
Methods
A cross-sectional survey of 2,050 average-risk adults aged 45–75 years was conducted at Qassim between December 2024 and February 2025. A structured questionnaire was used to collect socio-demographics, screening history, perceived barriers and facilitators, and knowledge of CRC symptoms and risk factors, utilizing a validated Cancer Awareness Measure (CAM). Logistic regression was used to identify predictors of FIT uptake.
Results
Acceptance of FIT was high (88.3%), but adherence to annual testing was low (43.1%). Knowledge of CRC was poor (mean CAM score 8.2/22), and only 15.2% showed good knowledge. In the multivariable analysis, reduced uptake was independently associated with poorer self-perceived health (OR = 0.19, 95% CI 0.05–0.78) and low CRC knowledge (poor: OR = 0.34, 95% CI 0.16–0.73; intermediate: OR = 0.21, 95% CI 0.09–0.46), whereas more frequent physician visits (2–5/year: OR = 1.57, 95% CI 1.07–2.31; >5/year: OR = 6.07, 95% CI 1.84–19.99), prior screening (OR = 2.02, 95% CI 1.30–3.14) and previous FIT (OR = 6.50, 95% CI 3.61–11.69) predicted higher uptake. Misconceptions, fear, and logistical issues limited participation, while mailed kits, electronic results, and physician counseling encouraged uptake.
Conclusion
In Qassim, FIT screening was widely accepted but poorly maintained, and CRC knowledge was low. National control of CRC will require accessible, patient-centered services and stronger public knowledge of symptoms and risk factors to support prevention, regular screening, and timely help-seeking.
Keywords: cancer awareness, colorectal cancer, fecal immunochemical test, health literacy, Saudi Arabia, screening adherence
1. Introduction
Colorectal cancer (CRC) is the third most common malignancy worldwide and the fifth leading cause of cancer-related death (1, 2). Globally, CRC incidence varies widely, with rates stabilizing in high-income countries but continuing to rise in low- and middle-income countries owing to lifestyle changes such as obesity, inactivity, and dietary patterns (3–5). In Saudi Arabia, CRC represents a major and rapidly escalating public health challenge. Data from the Saudi Cancer Registry and GLOBOCAN 2022 indicate that CRC is the most frequently diagnosed cancer in men and a leading cause of cancer-related mortality in both sexes (6, 7). Between 2002 and 2016, the age-standardized incidence rate increased by an average annual percentage change of 6.1% nationwide, with an even steeper increase observed in the Qassim region (7.8%) during the same period (8, 9). In 2023, age-standardized incidence rates reached 24.1 per 100,000 in men and 19.9 per 100,000 in women, exceeding rates reported in the Gulf Cooperation Council and neighboring countries, but remaining lower than those observed in many Western nations (10). Notably, this rapid increase places Saudi Arabia among the countries with the fastest-growing CRC burden worldwide (11, 12). This trend is largely attributed to population aging, urbanization, dietary changes, physical inactivity, and rising obesity prevalence (11–14). Established risk factors include alcohol, tobacco, red and processed meat, and excess body fat, whereas protective factors include fiber, whole grains, dairy, calcium, and regular physical activity (5).
Colonoscopy remains the gold standard for CRC screening; however, it is costly and resource-intensive, particularly in low-resource settings (15). The fecal immunochemical test (FIT) has therefore emerged as a cost-effective and acceptable alternative, with substantial evidence supporting its effectiveness and population uptake (16–18). The awareness of CRC symptoms (e.g., rectal bleeding, altered bowel habits, unexplained anemia, or weight loss) and recognition of modifiable risk factors are critical, since greater knowledge is consistently linked to higher screening uptake and earlier help-seeking (19–25).
To address the growing burden of CRC, the Saudi Ministry of Health launched an organized, population-based CRC screening program in 2017 that uses the FIT as the primary screening modality (26, 27). The program targets average-risk adults aged 45–75 years and offers annual FIT screening, free of charge, through public primary healthcare centers, with referral for diagnostic colonoscopy following a positive test. Nevertheless, effective CRC control depends not only on access to screening but also on public acceptance, sustained adherence, symptom recognition, and awareness of modifiable risk factors. Both prevention and early detection rely on these elements; however, regional data quantifying these factors remain limited.
Therefore, this study aimed to (i) assess the willingness of average-risk adults in the Qassim region to undergo FIT screening and identify key barriers and facilitators, and (ii) evaluate the knowledge and awareness of CRC symptoms and risk factors. These findings will inform strategies to strengthen prevention, promote early detection, and improve the long-term effectiveness of national CRC control efforts.
2. Methods
2.1. Study design and setting
This cross-sectional study was conducted among adults aged 45–75 years attending primary healthcare (PHC) centers in the Qassim region, Saudi Arabia, between December 1, 2024, and February 28, 2025. Ethical approval was obtained from the Regional Research Ethics Committee, Health and Curative Programs Department, Public Health and Community Health Administration, and Qassim Health Cluster (approval no. 607/46/827); approved on 29 July 2024. Written informed consent was obtained from all participants. This study was designed and reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines for cross-sectional studies (28).
The Qassim region included 149 PHC centers in the public sector that formed our sampling frame. An ongoing national CRC screening program provides a non-invasive, free-of-charge FIT. Individuals with positive results are referred for colonoscopy and further management. Eligible participants were adults aged 45–75 years who met the national criteria for average-risk CRC screening, had not undergone FIT in the preceding 12 months, and were able to provide informed consent and independently complete the survey. Participants were excluded if they were classified as high-risk (defined as CRC symptoms, inflammatory bowel disease, personal or family history of CRC or advanced adenomas, hereditary CRC syndromes, prior abdominal or pelvic radiation, or serrated polyposis syndrome). Participants were also excluded if they had undergone CRC screening within recommended intervals. These included completion of FIT within the past 12 months, colonoscopy within the previous 10 years, sigmoidoscopy within 5 years, stool DNA testing within 3 years, or CT colonography within 5 years.
The sample size was estimated using the OpenEpi software. Assumptions were informed by regional Ministry of Health CRC screening data from January to June 2024, which indicated an approximate refusal rate of 29% at the 95% confidence level and a 2% margin of error, yielding a minimum sample size of 1,974. To account for an anticipated response rate of 50%, 3,948 individuals were targeted, drawn from an estimated 143,871 adults aged 45–75 years residing in the Qassim region. Participants were recruited using consecutive sampling from all public primary healthcare centers across the Qassim region during routine clinical visits. This pragmatic, non-random approach was chosen to reflect the real-world implementation of the national screening program. All eligible individuals encountered during the study period were approached face-to-face and invited to participate until the target sample size was achieved.
2.2. Survey instrument and data collection
Data were collected using a structured, face-to-face interviewer-administered questionnaire adapted from the validated Bowel/Colorectal Cancer Awareness Measure (CAM), developed by the University College London and Cancer Research UK (29).
The questionnaire was administered in Arabic, the participants’ native language. The original English version underwent forward–backward translation by bilingual experts, content review by a multidisciplinary panel, and piloting with 30 adults to ensure clarity, cultural appropriateness and feasibility.
The instrument comprised six parts: Part A (Eligibility screen; 4 items); Part B (sociodemographic and clinical characteristics; 18 items), including age, sex, marital status, education, employment, BMI, smoking, residence (central [main cities] vs. peripheral areas), physical activity, participation in other screening programs, prior FIT uptake, and awareness of the local CRC screening program; Part C (Knowledge of FIT and CRC screening in Qassim; 4 items) covering awareness of the standard test, availability of the free program, recommended starting age, and test interval; Part D (Knowledge of CRC symptoms [10 items] and risk factors [12 items] using CAM) from which we derived the Symptom Knowledge Score (CAM-S), Risk Factor Knowledge Score (CAM-RF), and Total Knowledge Score (CAM-Total; 22 items); Part E (perceived barriers to FIT; 10 items); and Part F (facilitators of screening uptake; 7 items). Appendix 1 provides the English version of the questionnaire. Knowledge scores were categorized as poor, intermediate, or good using predefined thresholds: CAM-S (0–3, 4–7, 8–10), CAM-RF (0–4, 5–8, and 9–12), and CAM-Total (0–9, 10–17, and 18–22).
2.3. Statistical analysis
All analyses were performed using SPSS version 30 software (IBM Corp., Armonk, NY, United States). Descriptive statistics (frequencies, percentages, means, and standard deviations) were used to summarize participant characteristics. Internal consistency of the CRC Knowledge Scale and subscales was assessed using Cronbach’s α, which showed excellent reliability (α = 0.935 total CAM; α = 0.878 CAM-S; α = 0.901 CAM-RF). The item–total correlation confirmed that all items contributed meaningfully; the deletion of any item did not improve reliability, supporting the retention of the full scale. Associations between willingness to participate in FIT screening and sociodemographic, clinical, and knowledge variables were examined using the chi-square tests. Variables significant in the univariate analysis were entered into a multivariable logistic regression model to identify independent predictors of FIT uptake. Crude and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) are reported. Statistical significance was set at a two-sided p-value <0.05.
3. Results
3.1. Participant characteristics
Of the 2,675 individuals initially screened, 2,050 met the eligibility criteria and were included in the final analysis. Among them, 1,810 (88.3%) accepted the FIT test, whereas 240 (11.7%) refused to participate (Figure 1). The mean age of the participants was 56.4 years (SD ± 7.6), and 51.6% of the participants were female. The majority were married (92.3%), residing in peripheral areas (59.0%), or were unemployed (46.0%). More than half (55.0%) had completed high school or lower, and 76.9% were overweight or obese (median BMI = 27.6 kg/m2). Most participants reported good perceived health (72.8%), were nonsmokers (89.5%), and nearly half (48.9%) reported 2–5 physician visits in the past year. Regarding screening history, 79.0% had previously undergone at least one type of health screening, most commonly for diabetes (69.8%), and hypertension (61.1%). Breast cancer screening was reported by 34.6% of women and osteoporosis screening by 12.6% of participants. Among those with prior FIT screening who responded to the questions on test timing and regularity (n = 662), the majority (83.3%) had their last test in the previous year, although only 43.1% reported regular annual FIT uptake. The detailed sociodemographic and clinical characteristics are shown in Table 1.
Figure 1.
Flow diagram of study participants. Of the 2,675 individuals screened, 2,050 were included in the final analysis. Among these, 1,810 (88.3%) accepted fecal immunochemical test (FIT) screening and 240 (11.7%) declined participation.
Table 1.
Sociodemographic and health characteristics of study participants (n = 2,050).
| Characteristic | Category | N (%) |
|---|---|---|
| Age group | 45–54 | 461 (22.5) |
| 55–64 | 1,199 (58.5) | |
| 65–74 | 388 (18.9) | |
| Sex | Male | 993 (48.4) |
| Female | 1,057 (51.6) | |
| Marital status | Single | 30 (1.6) |
| Married | 1757 (92.3) | |
| Widowed/Separated | 116 (6.1) | |
| Education level | Illiterate | 477 (27.2) |
| High school or below | 963 (55.0) | |
| University/Postgraduate | 311 (17.8) | |
| Employment status | Employed | 533 (31.5) |
| Self-employed | 77 (4.6) | |
| Retired | 304 (18.0) | |
| Unemployed | 778 (46.0) | |
| Residence | Main cities | 756 (41.0) |
| Peripheral | 1,089 (59.0) | |
| Smoking status | Smoker | 64 (3.7) |
| Ex-smoker | 117 (6.8) | |
| Non-smoker | 1,541 (89.5) | |
| Physical activity | Active | 450 (24.8) |
| Moderate | 708 (39.0) | |
| Sedentary | 656 (36.2) | |
| BMI category | Obese | 630 (31.1) |
| Overweight | 927 (45.8) | |
| Normal | 466 (23.0) | |
| Perceived health | Good | 1,368 (72.8) |
| Moderate | 490 (26.1) | |
| Poor | 21 (1.1) | |
| Physician visits (last 12 months) | 0–1 time | 897 (43.8) |
| 2–5 times | 1,002 (48.9) | |
| >5 times | 151 (7.4) | |
| Any prior screening | Yes | 1,619 (79.0) |
| No | 431 (21.0) | |
| HTN screening | Yes | 1,253 (61.1) |
| No | 797 (38.9) | |
| DM screening | Yes | 1,431 (69.8) |
| No | 619 (30.2) | |
| BC screening | Yes | 366 (34.6) |
| No | 691 (65.4) | |
| Osteoporosis screening | Yes | 259 (12.6) |
| No | 1791 (87.4) | |
| FIT screening | Yes | 676 (33.0) |
| No | 1,374 (67.0) |
BMI, Body mass index; DM, Diabetes mellitus; HTN, Hypertension; BC, Breast cancer; FIT, Fecal immunochemical test.
3.2. Awareness of colorectal cancer screening in the Qassim region
Awareness of CRC screening programs varies widely among participants. While 52.9% correctly identified FIT as the standard screening method, 40.2% were unsure, and 6.9% believed that FIT was not the standard test. A greater proportion (63.0%) were aware that FIT was offered free of charge through the national program, although 32.5% did not know this, and 4.5% believed it was not free. Knowledge of the recommended starting age for screening was accurate among 56.8% of the respondents, who identified 45 years as the correct starting point, while 24.2% did not know, and the remainder selected older age thresholds. Awareness of the screening interval was limited. Only 8.5% correctly indicated that the FIT should be performed annually. In contrast, 41.7% believed that it was needed only once in their lifetime, and 37.4% did not know the appropriate frequency. Despite meeting the eligibility criteria, only 4.3% of the participants believed that they were at a higher risk for CRC, and more than half (56.9%) were unsure of their personal risk.
3.3. Colorectal cancer knowledge: symptoms and risk factors
Participants’ knowledge of CRC symptoms and risk factors was generally limited. The mean total CRC knowledge score was 8.2 out of 22 (SD = 6.6), with a median of 6 and an interquartile range (IQR) of 2–13. Based on predefined categories, 63.0% of the participants had poor overall knowledge, 21.9% had intermediate knowledge, and 15.2% had good knowledge. The mean symptom knowledge score was 3.9 out of 10 (SD = 3.1). Poor knowledge of symptoms was observed in 54.0% of participants, while 25.7% had intermediate knowledge, and 20.3% had good knowledge. The mean risk factor knowledge score was 4.3 out of 12 (SD = 3.9). Poor knowledge of risk factors was reported by 58.6%, intermediate knowledge by 22.6%, and good knowledge by 18.8%. The frequency of correct answers for the CAM total (22 items) is presented in Table 2.
Table 2.
Colorectal cancer awareness measure (CAM): symptom (CAM-S) and risk factor (CAM-RF), n = 2050.
| CAM-total items | Correct answer n (%) |
|---|---|
| Symptoms (CAM-S) | |
| Seek help promptly | 1,663 (81.1) |
| Blood in stool | 1,050 (51.2) |
| Abdominal lump | 955 (46.6) |
| Weight loss | 839 (40.9) |
| Abdominal pain | 697 (34.0) |
| Bowel habit change | 674 (32.9) |
| Rectal pain | 644 (31.4) |
| Anemia/fatigue | 639 (31.2) |
| Incomplete emptying | 550 (26.8) |
| Confidently noticing symptoms | 245 (12.0) |
| Risk factors (CAM-RF) | |
| Smoking | 1,154 (56.3) |
| Alcohol | 808 (39.4) |
| Low fruit/vegetable intake | 801 (39.1) |
| Overweight (BMI ≥ 25) | 758 (37.0) |
| Family history of CRC | 752 (36.7) |
| Low fiber diet | 731 (35.7) |
| Red/processed meat | 726 (35.4) |
| IBD (UC, Crohn’s) | 618 (30.1) |
| Diabetes | 611 (29.8) |
| Older age (>70 years) | 503 (24.5) |
| Low physical activity | 501 (24.4) |
| Perceived age most at risk | 245 (12.0) |
CAM, Cancer awareness measure; CAM-S, Symptom knowledge items; CAM-RF, Risk factor knowledge items; CAM-Total, Total knowledge items; IBD, Inflammatory bowel disease; UC, Ulcerative colitis.
Education level was significantly associated with knowledge (p = 0.002), with good knowledge reported by 19.0% of those with university or postgraduate education, compared to 11.1% of illiterate participants and 17.8% of those with high school or below. Perceived health status was also significant (p = 0.002), with only 4.8% of participants with poor health reporting good knowledge, compared to 12.0% with moderate health and 18.3% with good health. Perceived risk of CRC showed the strongest association (p < 0.001): participants who considered themselves at higher risk reported good knowledge most frequently (39.8%), compared to 20.7% of those responding “no” and 9.5% of those responding “I do not know”.
3.4. Refusal rate and barriers to participation in FIT-based colorectal cancer screening
Of the 2,050 participants, 240 (11.7%) declined to undergo FIT screening. The most frequent barriers were the belief that screening was unnecessary in the absence of symptoms (49.2%) or a family history of cancer (43.3%). Other reasons included fear of a positive result (36.3%), embarrassment (29.6%), inconvenience (31.3%), lack of time (29.2%), hesitancy toward colonoscopy follow-up (31.7%), and doubts regarding FIT effectiveness (14.2%).
In the univariate analysis, higher FIT participation was observed among women, unemployed individuals, participants with more frequent physician visits, those with a history of other health screenings, and individuals who had previously undergone FIT screening. Conversely, overweight participants and those with lower overall CRC knowledge were less likely to accept FIT. In the multivariate model, more frequent physician visits, prior participation in other health screening programs, and previous FIT testing remained independent predictors of higher screening uptake. In contrast, low overall CRC knowledge and poor self-perceived health were independently associated with reduced participation. The detailed results of the univariate and multivariate logistic regression analyses are presented in Table 3. Figures 2A–C illustrates that FIT refusal declined with increasing CRC knowledge scores for symptoms, risk factors, and total knowledge.
Table 3.
Logistic regression analysis of factors associated with participation in FIT screening.
| Variable | Univariate OR (95% CI) | p-value | Multivariate OR (95% CI) | p-value |
|---|---|---|---|---|
| Sociodemographic factors | ||||
| Sex (Female vs. Male) | 1.45 (1.11–1.91) | 0.01 | 1.38 (0.83–2.31) | 0.22 |
| Age (Ref: 45–54 years) | ||||
| 55–64 years | 0.83 (0.58–1.17) | 0.28 | 0.66 (0.40–1.09) | 0.10 |
| 65–74 years | 0.80 (0.53–1.23) | 0.32 | 0.72 (0.36–1.44) | 0.35 |
| Marital status (Ref: Single) | ||||
| Married | 0.60 (0.14–2.52) | 0.48 | – | – |
| Widowed/Separated | 0.96 (0.19–4.80) | 0.97 | – | – |
| Education (Ref: Illiterate) | ||||
| High school or below | 1.51 (0.94–2.44) | 0.09 | 0.68 (0.40–1.15) | 0.15 |
| University/Postgraduate | 1.20 (0.80–1.80) | 0.39 | 0.63 (0.31–1.29) | 0.21 |
| Employment status (Ref: Employed) | ||||
| Self-employed | 0.67 (0.35–1.29) | 0.23 | 0.90 (0.39–2.06) | 0.80 |
| Retired | 1.52 (0.94–2.48) | 0.09 | 1.42 (0.77–2.60) | 0.26 |
| Unemployed | 1.58 (1.09–2.28) | 0.02 | 1.35 (0.73–2.51) | 0.34 |
| Residence (Peripheral vs. Main cities) | 1.03 (0.76–1.39) | 0.86 | – | – |
| Health-related factors | ||||
| BMI (Ref: Normal) | ||||
| Obese | 0.77 (0.51–1.17) | 0.23 | 0.96 (0.53–1.75) | 0.90 |
| Overweight | 0.52 (0.36–0.76) | <0.001 | 0.59 (0.35–1.01) | 0.05 |
| Smoking status (Ref: Smoker) | ||||
| Ex-smoker | 0.56 (0.28–1.12) | 0.10 | – | – |
| Non-smoker | 0.90 (0.49–1.68) | 0.75 | – | – |
| Perceived health (Ref: Good) | ||||
| Moderate | 0.38 (0.28–0.52) | <0.001 | 0.30 (0.21–0.45) | <0.001 |
| Poor | 0.51 (0.15–1.77) | 0.29 | 0.19 (0.05–0.78) | 0.02 |
| Physical activity (Ref: Active) | ||||
| Moderate | 0.79 (0.54–1.16) | 0.23 | – | – |
| Sedentary | 0.98 (0.66–1.46) | 0.91 | – | – |
| Physician visits last 12 months (Ref: 0–1/year) | ||||
| 2–5 per year | 1.24 (0.94–1.63) | 0.13 | 1.57 (1.07–2.31) | 0.02 |
| >5 per year | 4.60 (1.85–11.44) | 0.001 | 6.07 (1.84–19.99) | 0.003 |
| Screening history | ||||
| History of other health screenings (Yes vs. No) | 2.48 (1.86–3.30) | <0.001 | 2.02 (1.30–3.14) | 0.002 |
| Screening for DM (Yes vs. No) | 1.74 (1.32–2.30) | <0.001 | – | – |
| Screening for HTN (Yes vs. No) | 1.52 (1.16–1.99) | 0.002 | – | – |
| Screening for BC (Yes vs. No) | 3.99 (2.20–7.24) | <0.001 | – | – |
| Screening for Osteoporosis (Yes vs. No) | 2.03 (1.21–3.38) | 0.007 | – | – |
| Previous FIT test (Yes vs. No) | 5.91 (3.74–9.35) | <0.001 | 6.50 (3.61–11.69) | <0.001 |
| CAM knowledge scores (Ref: Good) | ||||
| CAM-RF | ||||
| Poor | 0.84 (0.57–1.24) | 0.38 | – | – |
| Intermediate | 0.50 (0.33–0.77) | 0.002 | – | – |
| CAM-S | ||||
| Poor | 0.45 (0.29–0.70) | <0.001 | – | – |
| Intermediate | 0.37 (0.23–0.60) | <0.001 | – | – |
| CAM-Total | ||||
| Poor | 0.37 (0.22–0.65) | <0.001 | 0.34 (0.16–0.73) | 0.006 |
| Intermediate | 0.27 (0.15–0.48) | <0.001 | 0.21 (0.09–0.46) | <0.001 |
OR, Odds ratio; CI, Confidence interval; BMI, Body mass index; DM, Diabetes mellitus; HTN, Hypertension; BC, Breast cancer; FIT, Fecal immunochemical test; CAM, Cancer awareness measure; CAM-S, Symptom knowledge score; CAM-RF, Risk factor knowledge score; CAM-Total, Total knowledge score.
Figure 2.
Uptake of FIT screening stratified by colorectal cancer awareness scores. Acceptance and refusal are shown according to (A) Symptom Knowledge Score (CAM-S), (B) Risk Factor Knowledge Score (CAM-RF), and (C) Total Knowledge Score (CAM-Total). FIT, fecal immunochemical test; CAM, Cancer Awareness Measure.
3.5. Facilitators to improve colorectal cancer screening uptake among decliners
Among the 240 participants who declined FIT screening, several potential facilitators were identified. The most frequently cited factor was the option to receive the results electronically or by mail (45.8%), followed by encouragement from family members or peers who had previously undergone screening (45.0%). Logistical improvements, including mailing the FIT kit directly to participants (42.5%) and more convenient scheduling of screening and follow-up (42.1%), were also highlighted. Supportive physician–patient communication was considered valuable: 42.5% reported that a dedicated consultation with a primary care provider would increase their willingness to participate, and 42.1% endorsed additional support services to reduce anxiety about the process. Providing step-by-step instructions for obtaining and completing the test was cited by 39.2% of participants as a helpful facilitator.
4. Discussion
This study provides the first large-scale FIT-specific assessment of CRC screening in the Qassim region of Saudi Arabia and offers comprehensive insights into both uptake and awareness. The findings showed a high acceptance rate of FIT-based screening, with nearly nine out of 10 eligible participants agreeing to undergo the test. This uptake demonstrates the strong feasibility of scaling up organized programs. In this study, the refusal rate (11.7%) was lower than the rates reported internationally (22, 30), underscoring the feasibility and scalability of implementing organized CRC screening in the region (31). Notably, the demographic and health profiles of the participants were broadly consistent with national patterns, except for a higher proportion of illiterate participants in Qassim (27.2% vs. 3.4% nationally) (32). Despite this, screening acceptance was high, although knowledge scores were low across all educational levels, suggesting that general literacy may not necessarily translate into cancer-specific awareness.
Among those who declined the FIT test, misperceptions were the most prominent barrier. Nearly half believed screening was unnecessary in the absence of symptoms or a family history of cancer, reflecting the confusion between preventive screening and diagnostic evaluation. Psychological concerns, such as fear of results and embarrassment, and logistical challenges, including inconvenience and time constraints, discouraged participation. These findings align with reports from Saudi Arabia (33, 34), the United Arab Emirates (35, 36), and Lebanon (37), all of which identified misperceptions, stigma, and a lack of physician recommendations as common obstacles. Addressing these issues will require culturally tailored education, reassurance from trusted providers, and streamlined and more convenient screening pathways.
A major barrier revealed in this study was the persistently low knowledge of CRC symptoms and risk factors. The mean CAM score was only 8.2 out of 22, with only 15.2% of the participants classified as having good knowledge. Symptom recognition was particularly poor: while blood in stool was identified by half of the respondents, fewer than one-third recognized hallmark signs such as bowel habit changes, abdominal pain, or anemia. Risk factor knowledge was similarly limited, with smoking being the most frequently recognized, but obesity, diet, diabetes, family history, and inflammatory bowel disease were largely under-recognized. These findings are consistent with prior studies in Qatar (38), Lebanon (37), and the UAE (36), as well as with a broader review of the Middle East and North Africa (MENA) region (39). Importantly, participants with poor or intermediate CAM scores were significantly less likely to undergo screening, confirming that awareness is not only a theoretical measure but also a practical determinant of behavior. These findings indicate that substantial CRC knowledge gaps persist and should be addressed through targeted educational interventions integrated into screening delivery.
Despite strong initial acceptance, long-term adherence has emerged as a concern. While most participants accepted FIT screening, fewer than half of those with prior FIT experience adhered to the recommended annual schedule. Only 8.5% correctly identified the yearly interval, and this lack of awareness may partially explain the low regular participation. Inadequate understanding of recommended screening frequency, therefore, represents an important barrier to sustained adherence. Previous studies have similarly demonstrated that inadequate knowledge of screening intervals, together with the absence of reminder systems, are common challenges to maintaining regular participation in FIT-based screening programs (40–42). Sustained effectiveness of the program depends on transforming one-time participation into consistent adherence. Evidence suggests that reinforcing mechanisms such as SMS reminders, electronic health record prompts, and home-delivered FIT kits could improve regular uptake. Simplifying the test instructions and offering step-by-step guidance may also enhance compliance (43, 44).
Multivariate analysis identified key predictors of screening participation. Frequent physician contact and prior engagement in other health screenings were strong facilitators, indicating that individuals embedded in healthcare systems were more likely to comply with CRC screening. In contrast, participants with poorer self-perceived health, limited knowledge, or overweight were less likely to participate. These findings highlight the importance of integrating CRC screening into routine primary care encounters where providers can counsel and motivate patients. Among the decliners, logistical convenience, social encouragement, and dedicated provider consultations were identified as potential facilitators, further reinforcing the value of structural and interpersonal support.
These findings have significant implications. A high initial acceptance suggests that the population is receptive to CRC screening initiatives, but long-term success will depend on embedding annual FIT participation as a community norm. To achieve this, policymakers and healthcare providers must combine targeted education with structural support such as digital reminders, simplified logistics, and stronger provider–patient engagement. By addressing both cognitive and practical barriers, the program can enhance early detection, reduce the disease burden, and improve population-level outcomes.
This study has several strengths, including a large and diverse sample, the use of a validated awareness scale with excellent reliability, and linkage of knowledge levels, sociodemographic characteristics, and health behaviors with screening participation. However, this study has some limitations. Its cross-sectional design prevents drawing causal conclusions, and reliance on self-reported information may have introduced recall or social desirability bias, although the anonymous nature of data collection likely minimized these effects. In addition, the face-to-face, interviewer-administered format may have introduced interviewer bias, as the interviewer’s presence or phrasing could have influenced participants’ responses. To minimize this risk, interviewers received standardized training and used a structured questionnaire. Furthermore, the study was limited to a single region, which may limit the generalizability of the findings to other Saudi Arabian populations. Finally, although barriers and facilitators were explored, the effectiveness of specific interventions was not assessed, leaving this an important area for future research.
Saudi Arabia, with its young median age and steadily increasing life expectancy (45), is undergoing a demographic transition that will expand the population at risk for age-related diseases, including CRC. Given that advancing age is a major determinant of CRC incidence, the country is likely to face a substantial increase in CRC cases in the coming decades. Sustaining and expanding organized screening programs while addressing barriers and knowledge gaps will be essential for reducing future burden.
5. Conclusion
In Qassim, FIT screening is widely accepted but poorly maintained, while CRC knowledge is low. Multivariable analysis showed that reduced uptake was independently associated with poorer self-perceived health, fewer physician visits, and low CRC knowledge, whereas prior participation in other health screenings and previous FIT testing predicted higher uptake. Beyond screening behavior, limited knowledge also weakens prevention and delays timely help-seeking. Misconceptions, fear, and logistical challenges further hinder participation, while mailed kits, electronic result reporting, and physician counseling emerged as effective facilitators. For sustainable national control of CRC, efforts must combine accessible, patient-centered delivery with strategies to strengthen the knowledge of symptoms and risk factors, empower individuals to recognize early warning signs, and reinforce regular screening in asymptomatic adults.
Acknowledgments
The authors gratefully acknowledge the dedicated efforts of the screening program team members, including physicians, nurses, health educators, and administrative staff across primary healthcare centers in the Qassim region. Their commitment to implementing the colorectal cancer screening program, facilitating participant recruitment, and ensuring high-quality data collection was essential to the success of this study. The Researchers would like to thank the Deanship of Graduate Studies and Scientific Research at Qassim University for financial support (QU-APC-2025).
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Deanship of Graduate Studies and Scientific Research at Qassim University (grant no. QU-APC-2025).
Footnotes
Edited by: Iffat Elbarazi, United Arab Emirates University, United Arab Emirates
Reviewed by: Zsuzsanna Kívés, University of Pécs, Hungary
Zufishan Alam, Hamdan Bin Mohammed Smart University, United Arab Emirates
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
This study was approved by the Regional Research Ethics Committee of the Health and Curative Programs Department, Public Health and Community Health Administration, Qassim Cluster, Qassim Province (approval number 607/46/827). The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
BA: Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. TA: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing. RA: Conceptualization, Data curation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing. UR: Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that Generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fpubh.2026.1710204/full#supplementary-material
References
- 1.Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2024) 74:229–63. doi: 10.3322/caac.21834, [DOI] [PubMed] [Google Scholar]
- 2.International Agency for Research on Cancer . Cancer Today. (2025). Available online at: https://gco.iarc.fr/today/en/dataviz/maps-most-common-sites?mode=cancer&key=total&sexes=1&types=0 (Accessed Aug 20, 2025).
- 3.Fidler MM, Bray F, Vaccarella S, Soerjomataram I. Assessing global transitions in human development and colorectal cancer incidence. Int J Cancer. (2017) 140:2709–15. doi: 10.1002/ijc.30686, [DOI] [PubMed] [Google Scholar]
- 4.Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. (2017) 66:683–91. doi: 10.1136/gutjnl-2015-310912 [DOI] [PubMed] [Google Scholar]
- 5.A World Cancer Research Fund/AICR . Diet, nutrition, physical activity and colorectal cancer. (2025). Available online at: https://www.wcrf.org/dietandcancer/colorectal-cancer (Accessed Aug 23, 2025).
- 6.International Agency for Research on Cancer . Cancer today. Most common site per country, absolute numbers, mortality, both sexes, in 2022. (2025). Available online at: https://gco.iarc.fr/today/en [Accessed Dec 23, 2025).
- 7.Saudi Health Council . Saudi Cancer registry annual reports. Riyadh (Saudi Arabia): Saudi Health Council. (2025). Available online at: https://shc.gov.sa/en/NCC/Activities/Pages/NewAR.aspx (Accessed Dec 24, 2025).
- 8.Alyabsi M, Algarni M, Alshammari K. Trends in colorectal cancer incidence rates in Saudi Arabia (2001–2016) using the Saudi National Registry: early- versus late-onset disease. Front Oncol. (2021) 11:730689. doi: 10.3389/fonc.2021.730689, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Alshamsan B. Trends of cancer incidence in Qassim region, a descriptive analysis of data from the Saudi Cancer registry 2002–2016. Int J Health Sci (Qassim). (2022) 16:21–31. [PMC free article] [PubMed] [Google Scholar]
- 10.Saudi Health Council . Saudi Cancer Registry Annual Reports. Riyadh (Saudi Arabia): Saudi Health Council. (2023). Available online at: https://shc.gov.sa/en/NCC/Activities/Pages/NewAR.aspx (Accessed Dec 24, 2025).
- 11.Tian S, Wang Y-S, Wei D. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990–2021: a systematic analysis for the global burden of disease study 2021. Front Oncol. (2025) 15:1665430. doi: 10.3389/fonc.2025.1665430, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Jin X, Dong D, Xu Z, Sun M. The global burden of colorectal cancer attributable to high body-mass index in 204 countries and territories: findings from 1990 to 2021 and predictions to 2035. Front Nutr. (2024) 11:1473851. doi: 10.3389/fnut.2024.1473851, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Keum NN, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. (2019) 16:713–32. doi: 10.1038/s41575-019-0189-8, [DOI] [PubMed] [Google Scholar]
- 14.Basudan AM, Basuwdan AM, Abudawood M, Farzan R, Alfhili MA. Comprehensive retrospective analysis of colorectal cancer incidence patterns in Saudi Arabia. Life. (2023) 13:2198. doi: 10.3390/life13112198, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. (2025) 75:10–45. doi: 10.3322/caac.21871, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Schliemann D, Ramanathan K, Matovu N, O’Neill C, Kee F, Su TT, et al. The implementation of colorectal cancer screening interventions in low- and middle-income countries: a scoping review. BMC Cancer. (2021) 21:1266. doi: 10.1186/s12885-021-08809-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. (2022) 19:521–31. doi: 10.1038/s41575-022-00612-y, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Cusumano VT, May FP. Making FIT count: maximizing appropriate use of the fecal immunochemical test for colorectal cancer screening programs. J Gen Intern Med. (2020) 35:1870–4. doi: 10.1007/s11606-020-05728-y, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. (2020) 159:335–49.e15. doi: 10.1053/j.gastro.2020.02.068, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions. Cancer. (2010) 116:544–73. doi: 10.1002/cncr.24760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Nguyen CK, Phan HM, Lee CH, Do LAT. Assessing awareness of colorectal cancer symptoms among outpatients: a cross-sectional study at a hospital in Vietnam. Healthcare. (2023) 11:3132. doi: 10.3390/healthcare11233132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Adefemi K, Knight JC, Zhu Y, Wang PP. Racial and sociodemographic distribution of colorectal cancer screening in Canada: a cross-sectional study. Can J Public Health. (2024) 115:371–83. doi: 10.17269/s41997-024-00999-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Alyabsi M, Meza J, Islam KMM, Soliman A, Watanabe-Galloway S. Colorectal cancer screening uptake: differences between rural and urban privately insured population. Front Public Health. (2020) 8:564239. doi: 10.3389/fpubh.2020.564239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Post DM, Katz ML, Tatum C, Dickinson SL, Lemeshow S, Paskett ED. Determinants of colorectal cancer screening in primary care. J Cancer Educ. (2008) 23:241–7. doi: 10.1080/08858190802188957 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Tseng TS, Holt CL, Shipp M, Eloubeidi M, Britt K, Norena M, et al. Predictors of colorectal cancer knowledge and screening among church-attending African Americans and whites in the deep south. J Community Health. (2009) 34:90–7. doi: 10.1007/s10900-008-9122-7 [DOI] [PubMed] [Google Scholar]
- 26.Field Epidemiology Training Program . Evaluation of Participation and Performance Indicators in Colorectal Cancer Screening Program in Saudi Arabia from 2021 to 2023. (2023). Available online at: https://www.saudifetp.org/seb/evaluation-participation-and-performance-indicators-colorectal-cancer-screening-program-saudi (Accessed Dec 23, 2025).
- 27.Ministry of Health Saudi Arabia . Chronic Disease – Colorectal Cancer. (2025). Available online at: https://www.moh.gov.sa/en/awarenessplateform/ChronicDisease/Pages/ColorectalCancer.aspx (Accessed Aug 20, 2025).
- 28.Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. (2007) 147:573–7. doi: 10.7326/0003-4819-147-8-200710160-00010 [DOI] [PubMed] [Google Scholar]
- 29.Cancer Research UK . Cancer Awareness Measure “Plus” (CAM+). (2025). Available online at: https://www.cancerresearchuk.org/health-professional/awareness-and-prevention/the-cancer-awareness-measures-cam-plus (Accessed Aug 24, 2025).
- 30.Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C. Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. (2015) 64:282–91. doi: 10.1136/gutjnl-2013-306144, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Heitman SJ, Hilsden RJ, Au F, Dowden S, Manns BJ. Colorectal cancer screening for average-risk north Americans: an economic evaluation. PLoS Med. (2010) 7:e1000370. doi: 10.1371/journal.pmed.1000370, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Ministry of Education Saudi Arabia . Continuing education and literacy. (2025). Available online at: https://moe.gov.sa/en/education/generaleducation/pages/literacy.aspx (Accessed Aug 24, 2025).
- 33.Alhassan NS, Beyari MB, Aldeligan SH, Alqusiyer AA, Almutib SA, Alarfaj MA, et al. Understanding colorectal cancer screening barriers in Saudi Arabia: insights from a cross-sectional study. J Multidiscip Healthc. (2025) 18:1335–44. doi: 10.2147/JMDH.S465266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Busbait S. Exploring barriers to colorectal cancer screening in Saudi Arabia: findings from a cross-sectional study. Front Public Health. (2025) 13:1520191. doi: 10.3389/fpubh.2025.1520191, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Elbarazi I, Alam Z, Alshebli M, Alsunaidi L, Al-bluwi GSM, Faheem F, et al. Exploring knowledge, attitude, practices and barriers toward colorectal cancer screening in the United Arab Emirates: a mixed-methods study. Front Public Health. (2025) 13:1514484. doi: 10.3389/fpubh.2025.1514484 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Al Abdouli L, Dalmook H, Abdo MA, Carrick FR, Rahman MA. Colorectal cancer risk awareness and screening uptake among adults in the United Arab Emirates. Asian Pac J Cancer Prev. (2018) 19:2343–9. doi: 10.22034/APJCP.2018.19.8.2343, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Tfaily MA, Naamani D, Kassir A, Sleiman S, Ouattara M, Moacdieh MP, et al. Awareness of colorectal cancer and attitudes towards its screening guidelines in Lebanon. Ann Glob Health. (2019) 85:75. doi: 10.5334/aogh.2411 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Al-Dahshan A, Chehab M, Bala M, Omer M, AlMohamed O, Al-Kubaisi N, et al. Colorectal cancer awareness and its predictors among adults aged 50–74 years attending primary healthcare in the State of Qatar: a cross-sectional study. BMJ Open. (2020) 10:e035651. doi: 10.1136/bmjopen-2019-035651, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Alrubaiy L, El-sayed A, Kapila D, Akintimehin A, Wijeyendram P. Colorectal cancer screening in the Middle East and North Africa: current practices, challenges, and insights from the British Society of Gastroenterology (BSG) international section. Frontline Gastroenterol. (2025) 7:56. doi: 10.1136/flgastro-2025-102689 [DOI] [Google Scholar]
- 40.Fisher DA, Princic N, Miller-Wilson LA, Wilson K, DeYoung K, Ozbay AB, et al. Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer. Int J Color Dis. (2022) 37:719–21. doi: 10.1007/s00384-021-04055-w, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bardach SH, Schoenberg NE, Fleming ST, Hatcher J. The relationship between colorectal cancer screening adherence and knowledge among vulnerable rural residents of Appalachian Kentucky. Cancer Nurs. (2012) 35:288–97. doi: 10.1097/NCC.0b013e31822e7859, [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Benito L, Travier N, Binefa G, Vidal C, Espinosa J, Mila N, et al. Longitudinal adherence to immunochemical fecal occult blood testing vs guaiac-based FOBT in an organized colorectal cancer screening program. Cancer Prev Res (Phila). (2019) 12:327–34. doi: 10.1158/1940-6207.CAPR-18-0091, [DOI] [PubMed] [Google Scholar]
- 43.Belon AP, McKenzie E, Teare G, Nykiforuk CIJ, Nieuwendyk L, Kim M. (Olivia) et al. Effective strategies for fecal immunochemical tests (FIT) programs to improve colorectal cancer screening uptake among populations with limited access to the healthcare system: a rapid review. BMC Health Serv Res 2024;24:1176. doi: 10.1186/s12913-024-10573-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.O’Donoghue D, Sheahan K, MacMathuna P, Stephens RB, Fenlon H, Morrin M, et al. Data from a National Bowel Cancer Screening Programme Using FIT: Achievements and Challenges. AACR Cancer Discov data. (2023). Available online at: https://aacr.figshare.com/collections/Data_from_A_National_Bowel_Cancer_Screening_Programme_using_FIT_Achievements_and_Challenges/6547259/1 (Accessed Aug 26, 2025). [DOI] [PubMed]
- 45.United Nations . World Population Prospects. (2025). Available online at: https://population.un.org/wpp/ (Accessed Aug 26, 2025).
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


